$1.96
0.08 (+4.26%)
Ligand Pharmaceuticals, Inc. (LGND)
CAPS Rating:
Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases.

RSS Headlines
Fool UK
Recs
Avoid this like the plague. This is another one of those "Jack Of All Trades" companies that never really gets anywhere. Skip this until they get a better mission statement developed.